Stocks · Healthcare · Biotechnology
Viridian Therapeutics, Inc. VRDN
$19.40 +2.16% Close, Oct 2, 2026 · NASDAQ · Market cap $2.20B
Strong growth
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $71.1M, up 23220.3% from a year earlier, slowing from 23382.8% a quarter earlier.
- Operating margin widened to -569.7% from -121831.1% a year earlier.
- The diluted share count rose 32.2% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 1%
- Revenue growth, 3-year CAGRTop 2%
- Revenue growth accelerationBottom 2%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 34%
- Gross marginTop 6%
- Operating marginBottom 16%
- Accruals (lower is better)Bottom 42%
- Interest coverBottom 26%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 35%
- Free-cash-flow yieldBottom 30%
- EBITDA / enterprise valueBottom 31%
- Sales / enterprise valueBottom 16%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 39%
- 6-month returnBottom 46%
- 1-year return vs S&P 500Bottom 36%
- Distance from 52-week highBottom 36%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 33%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 31%
- Upside to consensus price targetTop 40%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 34%
- Maximum drawdown, 3 yearsTop 35%
- Beta vs S&P 500 (lower is better)Top 29%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 23382.8% | 23220.3% | ↓ |
| Gross margin | 100.0% | 99.6% | ↓ |
| Operating margin | -121831.1% | -569.7% | ↑ |
| FCF margin | -101507.9% | -471.0% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 23220.3% | 23382.8% | ↓ | Top 1% |
| Gross margin | 99.6% | 100.0% | ↓ | Top 6% |
| Operating margin | -569.7% | -121831.1% | ↑ | Bottom 16% |
| Net margin | -544.1% | -112806.9% | ↑ | — |
| Free-cash-flow margin | -471.0% | -101507.9% | ↑ | — |
| Return on invested capital | -39.2% | — | Bottom 34% | |
| Revenue growth, 3-year CAGR | 241.9% | — | Top 2% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 75.4%
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -21.4×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -22.27%
- Shareholder yield
- -22.27%
- Share count change, 1 year
- +32.2%
- Share count change, 3-year CAGR
- +35.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +12.9%
- Average 2-day reaction, last 8
- +3.3%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $36.43
- Target vs current price
- +87.8%
- Analysts with a rating
- 16
- Share rating Buy or Strong Buy
- 88%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | -1.9% | +6.8% | +8.6% | +8.1% | — |
| May 5, 2026 | +15.1% | +33.4% | +22.3% | +12.9% | +41.5% |
| Feb 26, 2026 | -20.0% | +1.9% | +5.0% | -2.0% | -38.9% |
| Nov 5, 2025 | +58.5% | +8.3% | +26.1% | +38.8% | +47.2% |
| Aug 6, 2025 | +0.0% | -1.4% | +3.0% | +11.6% | +31.9% |
| May 6, 2025 | +8.4% | -8.3% | +0.0% | +10.1% | +33.5% |
| Feb 27, 2025 | +22.9% | -1.5% | -1.6% | -8.8% | -12.0% |
| Nov 12, 2024 | -8.5% | -12.8% | -20.9% | -24.7% | -30.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$1.05 | -$1.03 | -1.9% | $284,000 |
| May 5, 2026 | -$0.90 | -$1.06 | +15.1% | $141,000 |
| Feb 26, 2026 | -$1.08 | -$0.90 | -20.0% | $132,000 |
| Nov 5, 2025 | -$0.34 | -$0.82 | +58.5% | $70.6M |
| Aug 6, 2025 | -$1.00 | -$1.00 | +0.0% | $75,000 |
| May 6, 2025 | -$0.87 | -$0.95 | +8.4% | $72,000 |
| Feb 27, 2025 | -$0.81 | -$1.05 | +22.9% | $72,000 |
| Nov 12, 2024 | -$1.15 | -$1.06 | -8.5% | $86,000 |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 32.00× | — | — | Bottom 16% |
| Free-cash-flow yield | -15.24% | — | — | Bottom 30% |
| Earnings yield | -18.20% | — | — | Bottom 35% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +4.7%
- 200-day average slope (20 days)
- -4.1%
- Distance from 50-day average
- -11.7%
- Distance from 200-day average
- -15.0%
- RSI (14)
- 36.0
- Relative volume
- 0.84×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 46.7%
- Volatility vs own 5-year history
- 10th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.74
- Correlation with S&P 500
- 0.19
- Current drawdown from 1-year high
- -42.6%
- Maximum drawdown, 3 years
- -60.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 26, 2023 | Apr 8, 2025 | -70.7% | 551 days | Not yet recovered |
| Jan 14, 2021 | May 9, 2022 | -61.7% | 331 days | 68 days (Aug 16, 2022) |
| Sep 28, 2020 | Oct 22, 2020 | -40.2% | 18 days | 4 days (Oct 28, 2020) |
| Aug 16, 2022 | Oct 24, 2022 | -26.4% | 48 days | 27 days (Dec 1, 2022) |
| Oct 29, 2020 | Nov 6, 2020 | -25.7% | 6 days | 43 days (Jan 11, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $2.20B
- EPS, diluted (TTM)
- -$3.53
- Revenue (TTM)
- $71.1M
- 52-week range
- $13.18 – $34.29
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $3.0M | $1.8M | $314,000 | $302,000 | $70.8M |
| Gross profit | $3.0M | $1.8M | $314,000 | $302,000 | $70.8M |
| Operating income | -$79.7M | -$134.3M | -$254.4M | -$299.0M | -$363.4M |
| Net income | -$79.4M | -$129.9M | -$237.7M | -$269.9M | -$342.6M |
| EPS (diluted) | -$6.66 | -$3.91 | -$5.31 | -$3.98 | -$3.32 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $86,000 | $72,000 | $72,000 | $75,000 | $70.6M | $132,000 | $141,000 | $284,000 |
| Net income | -$76.7M | -$79.7M | -$86.9M | -$100.7M | -$34.6M | -$120.4M | -$104.9M | -$127.1M |
| EPS (diluted) | -$1.15 | -$0.81 | -$0.87 | -$1.23 | -$0.34 | -$1.11 | -$1.03 | -$1.05 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$54.6M | -$93.8M | -$184.2M | -$232.3M | -$276.4M |
| Capital expenditure | -$338,000 | -$797,000 | -$898,000 | -$511,000 | -$495,000 |
| Free cash flow | -$54.9M | -$94.6M | -$185.1M | -$232.8M | -$276.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $114.2M | $291.9M | $125.1M | $453.7M | $348.3M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $981.5M
- Total assets
- $1.10B
- Total liabilities
- $435.1M
- Total debt
- $242.9M
- Net debt
- $77.9M
- Shareholders’ equity
- $662.1M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 19,465,251
- Days to cover
- 15.74
- Change vs previous report
- -0.2%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Nov 13, 2020
- 1-for-15
- Nov 7, 2016
- 1-for-15